PDCD1 and cancer: These include (i) cytokine signaling in the immune system, (ii) MAPK signaling pathway, (iii) PD-L1 expression, and PD-1 checkpoint pathway in cancer, (iv) platelet activation, (v) Innate immune system, and (vi) C-type lectin receptor signaling pathways (Fig. 1B).